Heidi Hagen serves as Executive at ZIOPHARM ONCOLOGY INC, where they oversee executive responsibilities. Since joining the company, Heidi Hagen has executed 11 insider transactions totaling $41.8K, demonstrating a bullish approach to their equity position. Their most recent transaction on May 1, 2024 involved exercising options for 3,200 shares valued at $0.
Heidi Hagen currently holds 18,650 shares of ZIOPHARM ONCOLOGY INC (ZIOP), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Heidi Hagen has been a net buyer of ZIOP stock. They have purchased $41.8K and sold $0 worth of shares.
Heidi Hagen's most recent insider trade was on May 1, 2024, when they sold 3,200 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| 2,600 |
| $N/A |
| Discretionary |
| Apr 27, 2022 | VCEL | $0 | Option Exercise | 2,600 | $N/A | Discretionary |
| Sep 2, 2021 | ZIOP | $41.8K | Purchase | 23,770 | $1.76 | Discretionary |
| May 19, 2021 | VCEL | $13.5K | Option Exercise | 2,250 | $6.00 | Discretionary |
| May 19, 2021 | VCEL | $12.4K | Option Exercise | 3,000 | $4.12 | Discretionary |
| May 19, 2021 | VCEL | $9.0K | Option Exercise | 1,500 | $6.00 | Discretionary |
| Apr 28, 2021 | VCEL | $0 | Option Exercise | 1,750 | $N/A | Discretionary |
| Mar 4, 2021 | ZIOP | $0 | Award | 90,000 | $N/A | Discretionary |
| Apr 29, 2020 | VCEL | $0 | Option Exercise | 1,750 | $N/A | Discretionary |
| Dec 31, 2019 | ZIOP | $0 | Award | 31,780 | $N/A | Discretionary |